Structure Therapeutics Inc. (GPCR) /
The debt of Structure Therapeutics Inc. over the past 4 years
Chart Structure Therapeutics Inc.: liquid cash, total debt, net cash, fiscal 2022–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, Structure Therapeutics Inc. had liquid cash of $1.45B and total debt of $0: net cash of $1.45B. It had more liquid cash than debt at all 4 year-ends shown.
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $1.45B* | $0 | $1.45B |
| 2024ended Dec 31, 2024 | $883.52M* | $0 | $883.52M |
| 2023ended Dec 31, 2023 | $467.32M* | $0 | $467.32M |
| 2022ended Dec 31, 2022 | $90.84M* | $0 | $90.84M |
Fiscal years as Structure Therapeutics Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Structure Therapeutics Inc.
- The profitability of Structure Therapeutics Inc.
- The cash flow of Structure Therapeutics Inc.
- All of Structure Therapeutics Inc.'s financials, charted
Companies of a similar size
- BCOBRINK’S CO
- STWDStarwood Property Trust, Inc.
- JOBYJoby Aviation, Inc.
- SIGSIGNET JEWELERS LIMITED
- OKLOOklo Inc.
Not investment advice. This page shows what Structure Therapeutics Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.